All bills
H.R. 10471·119th Congress·House Bill

CLAIM Act

Stage not supplied

The source supplies the latest action, but no lifecycle stage.

Latest action (16 Sep 2026): Referred to the House Committee on Financial Services.

What this bill does

The proposed bill, H.R. 10471, known as the CLAIM Act, aims to create a "safe harbor" for insurance companies that provide services to legitimate businesses involved with cannabis. It defines various terms related to cannabis and businesses that handle it under state law. The bill would prevent federal agencies from penalizing or discouraging insurers from offering policies to these businesses or individuals associated with them. It also specifies that insurers and their employees would not be held liable under federal law solely for engaging in the insurance business with a cannabis-related legitimate business or for investing income derived from it.

This legislation would directly affect insurers, cannabis-related legitimate businesses, and their owners, operators, and employees. It seeks to protect them from adverse actions by federal agencies. Additionally, the bill mandates a study by the Government Accountability Office (GAO) on the challenges faced by minority- and women-owned cannabis businesses in accessing financial services and entering the market. The GAO would then report its findings and any recommendations to Congress.

H.R. 10471 was introduced in the House of Representatives and has been referred to the House Committee on Financial Services. The next step in the legislative process would be for the committee to consider the bill, potentially holding hearings or proposing amendments. If approved by the committee, it could then be considered by the full House of Representatives.

Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.

Timeline

  1. 16 Sep 2026

    Referred to the House Committee on Financial Services.

Common questions

What does H.R. 10471 do?
The proposed bill, H.R. 10471, known as the CLAIM Act, aims to create a "safe harbor" for insurance companies that provide services to legitimate businesses involved with cannabis. It defines various terms related to cannabis and businesses that handle it under state law. The bill would prevent federal agencies from penalizing or discouraging insurers from offering policies to these businesses or individuals associated with them. It also specifies that insurers and their employees would not be held liable under federal law solely for engaging in the insurance business with a cannabis-related legitimate business or for investing income derived from it. This legislation would directly affect insurers, cannabis-related legitimate businesses, and their owners, operators, and employees. It seeks to protect them from adverse actions by federal agencies. Additionally, the bill mandates a study by the Government Accountability Office (GAO) on the challenges faced by minority- and women-owned cannabis businesses in accessing financial services and entering the market. The GAO would then report its findings and any recommendations to Congress. H.R. 10471 was introduced in the House of Representatives and has been referred to the House Committee on Financial Services. The next step in the legislative process would be for the committee to consider the bill, potentially holding hearings or proposing amendments. If approved by the committee, it could then be considered by the full House of Representatives.
Has H.R. 10471 become law?
The source does not supply a confirmed lifecycle stage for H.R. 10471. Check the latest action and official source below.
Who sponsored H.R. 10471?
H.R. 10471 was sponsored by Rep. Velázquez, Nydia M. [D-NY-7] (D-NY), with 1 cosponsor.
What's the latest action on H.R. 10471?
Referred to the House Committee on Financial Services. (16 Sep 2026).

Related bills in Finance and Financial Sector

More bills from Rep. Velázquez, Nydia M. [D-NY-7]

Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.